MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valv… Read more
MicroPort CardioFlow Medtech Corporation (MROPF) - Net Assets
Latest net assets as of June 2025: $2.22 Billion USD
Based on the latest financial reports, MicroPort CardioFlow Medtech Corporation (MROPF) has net assets worth $2.22 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.67 Billion) and total liabilities ($450.55 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.22 Billion |
| % of Total Assets | 83.11% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 4.26 |
MicroPort CardioFlow Medtech Corporation - Net Assets Trend (2020–2024)
This chart illustrates how MicroPort CardioFlow Medtech Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for MicroPort CardioFlow Medtech Corporation (2020–2024)
The table below shows the annual net assets of MicroPort CardioFlow Medtech Corporation from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $2.22 Billion | -4.85% |
| 2023-12-31 | $2.33 Billion | -15.21% |
| 2022-12-31 | $2.75 Billion | -11.07% |
| 2021-12-31 | $3.10 Billion | +997.05% |
| 2020-12-31 | $-345.18 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to MicroPort CardioFlow Medtech Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 179454400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $3.98 Billion | 182.05% |
| Total Equity | $2.19 Billion | 100.00% |
MicroPort CardioFlow Medtech Corporation Competitors by Market Cap
The table below lists competitors of MicroPort CardioFlow Medtech Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Syscom Computer Engineering Co
TW:2453
|
$99.66 Million |
|
Orthocell Ltd
AU:OCC
|
$99.69 Million |
|
Zhuhai Sailong Pharmaceutical Co Ltd
SHE:002898
|
$99.73 Million |
|
Shandong Molong Petroleum Machinery Company Limited
PINK:SHANY
|
$99.73 Million |
|
X-Legend Entertainment Co Ltd
TW:4994
|
$99.66 Million |
|
icad inc
NASDAQ:ICAD
|
$99.64 Million |
|
Asia Paper
KO:002310
|
$99.62 Million |
|
ASolid Technology Co Ltd
TWO:6485
|
$99.59 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MicroPort CardioFlow Medtech Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,334,863,000 to 2,187,212,000, a change of -147,651,000 (-6.3%).
- Net loss of 49,446,000 reduced equity.
- Share repurchases of 39,124,000 reduced equity.
- New share issuances of 129,000 increased equity.
- Other factors decreased equity by 59,210,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-49.45 Million | -2.26% |
| Share Repurchases | $39.12 Million | -1.79% |
| Share Issuances | $129.00K | +0.01% |
| Other Changes | $-59.21 Million | -2.71% |
| Total Change | $- | -6.32% |
Book Value vs Market Value Analysis
This analysis compares MicroPort CardioFlow Medtech Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.14x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $-0.15 | $0.13 | x |
| 2021-12-31 | $1.29 | $0.13 | x |
| 2022-12-31 | $1.14 | $0.13 | x |
| 2023-12-31 | $0.97 | $0.13 | x |
| 2024-12-31 | $0.92 | $0.13 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MicroPort CardioFlow Medtech Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2.26%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.68%
- • Asset Turnover: 0.14x
- • Equity Multiplier: 1.22x
- Recent ROE (-2.26%) is above the historical average (-8.98%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 0.00% | -383.02% | 0.09x | 0.00x | $-363.57 Million |
| 2021 | -5.92% | -91.26% | 0.06x | 1.09x | $-492.91 Million |
| 2022 | -16.50% | -181.02% | 0.08x | 1.09x | $-729.77 Million |
| 2023 | -20.20% | -140.25% | 0.13x | 1.10x | $-705.02 Million |
| 2024 | -2.26% | -13.68% | 0.14x | 1.22x | $-268.17 Million |
Industry Comparison
This section compares MicroPort CardioFlow Medtech Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MicroPort CardioFlow Medtech Corporation (MROPF) | $2.22 Billion | 0.00% | 0.20x | $99.66 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |